Research & Development



  既然他們自己都不知道自愛,雲瑯自然會壓迫這些人壓迫的心安理得,且沒有愧疚感。   看著閨女圍著雪人做各種怪模樣,劉徹問阿嬌。好屌日   司馬相如冷笑道︰“不堪入目!”好屌色免费在线视频   “天馬徠從西極。經萬里兮歸有德。承靈威兮降外國。涉流沙兮四夷服。”   皇帝悠長的呼吸聲從床幃中傳出,鐘離遠就熄滅了鶴嘴燈,兩個宮女,兩個宦官悄悄地出現,跪坐在黑暗中。久久综合色久久88中文   隋越想了想,堅決的搖頭道︰“沒有,不是他越來越像陛下,而是陛下越來越像他!

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo